Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin J Maly

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
ACS Chemical Biology|May 27, 2016
Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive LigandsHannah C Feldman, Michael Tong, Likun Wang, et al.
Nature Chemical Biology|September 24, 2021
ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPRHannah C Feldman, Rajarshi Ghosh, Vincent C Auyeung, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
International Journal for Parasitology|September 14, 2017
In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoitesAlejandro Jiménez-Meléndez, Kayode K Ojo, Alexandra M Wallace, et al.
Cancer Research|November 2, 2019
Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and SurvivalPaul C Moore, Jenny Y Qi, Maike Thamsen, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Cell Metabolism|May 4, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
ACS Chemical Biology|May 27, 2016
Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive LigandsHannah C Feldman, Michael Tong, Likun Wang, et al.
Nature Chemical Biology|September 24, 2021
ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPRHannah C Feldman, Rajarshi Ghosh, Vincent C Auyeung, et al.
The Journal of Infectious Diseases|June 11, 2019
P-Glycoprotein-Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite CryptosporidiumSamuel L M Arnold, Ryan Choi, Matthew A Hulverson, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift AssaysSuzanne Scheele, Jennifer A Geiger, Amy E DeRocher, et al.
International Journal for Parasitology|September 14, 2017
In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoitesAlejandro Jiménez-Meléndez, Kayode K Ojo, Alexandra M Wallace, et al.
Cancer Research|November 2, 2019
Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and SurvivalPaul C Moore, Jenny Y Qi, Maike Thamsen, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Cell Metabolism|May 4, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Pageof 13